154
Participants
Start Date
July 9, 2024
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
endoscopic surgery
The tumor was resected by endoscopic nasopharyngectomy.
Neoadjuvant therapy,Toripalimab Injection and Gemcitabine based therapy
Two courses of Toripalimab Injection and two courses of Toripalimab Injection and Gemcitabine based chemotherapy were given before endoscopic surgery.
Adjuvant therapy in experimental group,Toripalimab Injection and Gemcitabine based therapy
Eight courses of Toripalimab Injection and two to four courses of chemotherapy, or until unacceptable side effects.
Adjuvant therapy in control group,Toripalimab Injection and Gemcitabine based therapy
Ten courses of Toripalimab Injection and four to six courses of chemotherapy,or until unacceptable side effects.
RECRUITING
Eye& ENT Hospital, Fudan University, Shanghai
NOT_YET_RECRUITING
Fujian Medical University Union Hospital, Fuzhou
RECRUITING
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning
NOT_YET_RECRUITING
Changhai Hospital, Shanghai
NOT_YET_RECRUITING
Shanghai Sixth People's Hospital, Shanghai
NOT_YET_RECRUITING
Shanghai Zhongshan Hospital, Shanghai
NOT_YET_RECRUITING
Shenzhen Second People's Hospital, Shenzhen
Shanghai Zhongshan Hospital
OTHER
Shanghai 6th People's Hospital
OTHER
Changhai Hospital
OTHER
Fujian Medical University Union Hospital
OTHER
People's Hospital of Guangxi Zhuang Autonomous Region
OTHER
Shenzhen Second People's Hospital
OTHER
Eye & ENT Hospital of Fudan University
OTHER